Triveni Bio Secures $65M to Advance TRIV-573 Development
WATERTOWN, Mass., June 17, 2026 Triveni Bio, a clinical-stage biotechnology company developing innovative antibody therapies for immunological and inflammatory...
drug development
Advertisement
Dimerix Licenses DMX-200 to Everest Medicines in Asia
MELBOURNE, Australia, June 16, 2026 Dimerix Limited has announced a landmark exclusive licensing agreement with Everest Medicines for the...
Jazz Presents New Xywav Data at SLEEP 2026 Meeting
DUBLIN, Ireland, June 16, 2026 Jazz Pharmaceuticals plc has unveiled extensive late-breaking research at SLEEP 2026, presenting 11 new...
Niowave and Ratio Partner to Advance Actinium-225 Supply
LANSING, Mich. and BOSTON, Mass., June 16, 2026 Niowave, Inc. and Ratio Therapeutics Inc. have entered into a strategic...
Optimi Health Launches Standardized Psilocybin Microdose Capsules for Clinical Research
VANCOUVER, British Columbia, June 16, 2026 Optimi Health Corp. has announced the commercial production of two new standardized microdose...
Advertisements
Takeda Oveporexton Shows Broad Benefits in Narcolepsy
OSAKA, Japan and CAMBRIDGE, Massachusetts, June 15, 2026 Takeda has unveiled new pivotal Phase 3 data demonstrating that oveporexton...
Gilead’s Once-Weekly Yeztugo Accepted by FDA for HIV Prevention Review
FOSTER CITY, Calif., June 16, 2026 Gilead Sciences has announced that the U.S. Food and Drug Administration (FDA) has...
Halia Therapeutics Secures FDA Fast Track for Ofirnoflast
LEHI, Utah, June 15, 2026 Halia Therapeutics has announced that the U.S. Food and Drug Administration (FDA) has granted...
Halozyme Reaffirms Long-Term Royalty Growth Despite Proposed Medicare Pricing Changes
SAN DIEGO, June 15, 2026 Halozyme Therapeutics, Inc. has confirmed that it expects zero to minimal impact on royalty...
Enhanced Group Secures $50 Million Financing to Accelerate Health Platform Growth
NEW YORK, June 15, 2026 Enhanced Group Inc. has announced a $50 million strategic equity financing through a private...
Advertisement
